T Cell Response in Hypersensitivity Syndrome

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
University Hospital, Rouen
ClinicalTrials.gov Identifier:
NCT00213447
First received: September 13, 2005
Last updated: June 17, 2013
Last verified: June 2013
  Purpose

immunological study of the T cell repertoire phenotype and functionality in hypersensitivity syndrome.


Condition
Hypersensitivity
Syndrome

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective
Official Title: Characterization of T Cell Response in Hypersensitivity Syndrome

Resource links provided by NLM:


Further study details as provided by University Hospital, Rouen:

Estimated Enrollment: 40
Study Start Date: November 2002
Estimated Study Completion Date: December 2005
  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population

patients with Drug rash with eosinophilia and systemic symptoms

Criteria

Inclusion Criteria:

  • age > 18
  • cutaneous eruption
  • lymph nodes
  • hepatitis
  • interstitial pneumonia
  • nephritis
  • cardiopathy
  • eosinophilia
  • hyperlymphocytosis

Exclusion Criteria:

  • age minor to 18
  • HIV +
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00213447

Locations
France
UH-Rouen
Rouen, France
Sponsors and Collaborators
University Hospital, Rouen
Investigators
Principal Investigator: Pascal Joly, MD-PHD UH rouen
  More Information

No publications provided by University Hospital, Rouen

Additional publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Responsible Party: University Hospital, Rouen
ClinicalTrials.gov Identifier: NCT00213447     History of Changes
Other Study ID Numbers: 2001/056/HP
Study First Received: September 13, 2005
Last Updated: June 17, 2013
Health Authority: France: Ministry of Health

Additional relevant MeSH terms:
Hypersensitivity
Drug Hypersensitivity Syndrome
Immune System Diseases
Drug Eruptions
Dermatitis
Skin Diseases
Drug Hypersensitivity
Drug-Related Side Effects and Adverse Reactions
Chemically-Induced Disorders

ClinicalTrials.gov processed this record on August 27, 2014